Journals / Van Tıp Dergisi / 2016 / Cilt: 23 - Sayı: 4

Postmenopozal Düşük Seviye HCG ve Yönetimi: Olgu Sunumu

Postmenopausal Low Level HCG and Management: A Case Report

Pages
357–359
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason, it is important to avoid unnecessary invasive procedures and medical practices involving the use of chemotherapeutics to make accurate differential diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In our case report 51-year-old, 1-year menopausal status, hCG positive, patient is discussed.
📊
Key Findings & Data:Persistent low-level hCG secretion may be seen in such cases as: early pregnancy, gestational trophoblastic disease session, false positive hCG, pituitary hCG, non-gestational malignancies.
💡
Conclusion & Impact:For this reason, it is important to avoid unnecessary invasive procedures and medical practices involving the use of chemotherapeutics to make accurate differential diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In our case report 51-year-old, 1-year menopausal status, hCG positive, patient is discussed. Persistent low-level hCG secretion may be seen in such cases as: early pregnancy, gestational trophoblastic disease session, false positive hCG, pituitary hCG, non-gestational malignancies. When the conditions causing the elevated hCG are analyzed, it should not be forgotten that persistent low level hCG is experienced not only in pathological situations but also in physiological conditions. For this reason, it is important to avoid unnecessary invasive procedures and medical practices involving the use of chemotherapeutics to make accurate differential diagnosis.

Özet

Olgu sunumuzda 1 yıllık menapozal statüde hCG pozitifliği tespit edilen 51 yaşındaki vaka tartışılmıştır. Düşük persiste hCG salınımı; erken gebelik dönemi, aktif gestasyonel trofoblastik hastalık, yanlış hCG pozitifliği, nongestasyonel maligniteler ve hipofizer kaynaklı hCG salınımı gibi durumlarda karşımıza çıkabilmektedir. hCG yüksekliğine neden olan durumlar incelendiğinde postmenopozal dönemdeki düşük seviye persiste hCG tespitinin her zaman patolojik durumlarla birlikte olmadığı, fizyolojik durumlarla da birlikte olabileceği unutulmamalıdır. Bu nedenle ayrıcı tanının net yapılarak, gereksiz invaziv işlem, kemoterapötik kullanımına varan tıbbi uygulamalardan kaçınılması önem arz etmektedir.

🔖

Cite This Article

GÜLER, A. E., PEHLİVAN, H., ÖZEK, A., KOLUSARI, A. (2016). Postmenopozal Düşük Seviye HCG ve Yönetimi: Olgu Sunumu. Van Tıp Dergisi, Cilt: 23 - Sayı: 4, 357–359. https://ajindex.com/articles/334547

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Niemann I, Vejerslev LO, Frİding L, Blaakær J, Maroun LL, Hansen ES, et al. Gestational trophoblastic diseases-clinical guidelines for diagnosis, treatment, follow-up, and counselling. Dan Med J 2015; 62(11):A5082. Cole LA, Khanlian SA. Inappropriate management of women with persistent low hCG results. J Repro Med 2004; 49(6): 423-432.
  2. Cole LA, Dai D, Butler SA, Leslie KK, Kohorn El. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. Gynecol Oncol 2006; 102(2): 145-150.
  3. Cole LA, Ladner DG, Byrn FW. The normal variabilities of the menstrual cycle. Fertil Steril 2009; 91(2): 522-527.
  4. Narayan P, Gray J, Puett D. Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive. Mol Endocrinol 2002; 16(12): 2733-2745.
  5. Pillai RN, Konje JC, Tincello DG, Potdar N. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis. Hum Reprod Update 2016; 22(2): 228-239. Cole LA. Use of hCG tests for evaluating trophoblastic diseases: Choosing an appropriate hCG assay, false detection of hCG, unexplained elevated hCG, and quiescent trophoblastic disease. In: Gestational Trophoblastic Disease, 2nd, Hancock BW, Newland ES, Berkowitz RS, Cole LA (Eds), Chapman and Hall, London 2002. p.130. Hancock BW, Tidy JA. Clinical management of persistent low-level hCG elevation. Trophobl Dis Upd 2004; 4: 5-6. Kohorn EI. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Gynecol Oncol 2002; 85(2): 315- 320. Narayan P. Genetic Models for the Study of Luteinizing Hormone Receptor Function. Front Endocrinol (Lausanne) 2015; 6: 152.